tryptophan has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braicu, IE; Concin, N; Fuchs, D; Gostner, JM; Mahner, S; Obermayr, E; Sehouli, J; Vanderstichele, A; Vergote, I; Zeillinger, R | 1 |
| Fan, L; Ge, T; Guo, B; Hou, Y; Ke, C; Li, K; Lou, G; Wang, J; Yang, K; Zhang, F; Zhang, H | 1 |
2 other study(ies) available for tryptophan and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Middle Aged; Neoplasms, Glandular and Epithelial; Neoplastic Cells, Circulating; Neopterin; Ovarian Neoplasms; Tryptophan | 2018 |
Large-scale profiling of metabolic dysregulation in ovarian cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Humans; Metabolomics; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Tryptophan | 2015 |